Sysmex South Africa

Breast Cancer is a challenge best faced together

One in eight women in Europe will develop breast cancer at some stage in her life. Yet closer cooperation between specialists, new diagnostics and therapies have improved survival rates significantly1,2 as well as Patients’ quality of life.3-5 

Sysmex is playing a significant role in these improvements for you as a clinician, and your patients.

  • Eliminate concerns regarding guidewire or radioactive makers for impalpable lesion localisation by using the Sentimag® / Magseed® system for true convenience for you and your patients.
  • Your patients can benefit from tissue-saving operations and fewer long-term effects thanks to the sentinel lymph node biopsy (SNLB) concept.
  • You no longer need radioactive markers to detect sentinel lymph nodes as the Sentimag® / Sienna+® system detects them magnetically.
  • Get reliable findings based on whole nodes – not just slices – using OSNA’s molecular lymph node analysis; also inter-operatively. It’s shown to help deliver individualised therapy decisions too.
  • Reduce your patients’ limitations in everyday life using modern breast cancer management even with the most essential, systemic cancer treatment.

Read inspiring survivor stories

They share words of inspiration, hope and how their lives have been changed by breast cancer.


  1. SEER Stat Fact Sheets: Female Breast Cancer. (accessed Sep. 20, 2016).
  2. Allemani C. et al. (2015): Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887
    patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet, 385:977-1010.
  3. Kirshbaum M.N. et al. (2016): Open access follow-up care for early breast cancer: a randomised controlled quality of life analysis. Eur. J. Cancer Care, advance online publication, doi: 10.1111/ecc.12577.
  4. Hamer J. et al. (2016): Quality of life (QOL) and symptom burden (SB) in patients with breast cancer. Support Care Cancer, advance online publication, doi:10.1007/s00520-016-3417-6.
  5. Pinto A.C. et al.(2011): Improving quality of life after breast cancer: dealing with symptoms. Maturitas, 70(4):343-348.

Endomag®, Sentimag®, Magseed® and Sienna+® are registered European Community Trademarks of Endomagnetics Ltd.

Watch our videos

Molecular intraoperative staging with OSNA

Molecular intraoperative staging with OSNA

Magseed placement in radiology

Magseed placement in radiology

Lesion localisation with Magseed in surgery

Lesion localisation with Magseed in surgery

Copyright © Sysmex Europe SE. All rights reserved.
Customize your experience

We use cookies to enable you to optimally use our Website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

* May lead to restrictions in content and in the user experience
Detail about cookies
Essential cookies
These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.
Statistics cookies
By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.
Marketing cookies
are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.